Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Subject Information and Consent Form F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and Pain

ClinicalTrials.gov ID: NCT00036335

Public ClinicalTrials.gov record NCT00036335. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 8:43 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Duloxetine Hydrochloride (LY248686) Protocol F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and Pain

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purposes of this study are to determine whether an investigational drug can help patients suffering from major depression with pain symptoms, and gather data on the safety of the investigational drug including any side effects that might be associated with it.

Study identification

NCT ID
NCT00036335
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
286 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2002 (Type not available)
Primary completion
Not listed
Completion
Jan 2003 (Type not available)
Last update posted
Jul 19, 2006

2002 – 2003

United States locations

U.S. sites
25
U.S. states
17
U.S. cities
25
Facility City State ZIP Site status
Not listed Peoria Arizona — —
Not listed Burbank California — —
Not listed Fresno California — —
Not listed St. Petersburg Florida — —
Not listed West Palm Beach Florida — —
Not listed Atlanta Georgia — —
Not listed Oakbrook Terrace Illinois — —
Not listed Springfield Illinois — —
Not listed Glen Burnie Maryland — —
Not listed Farmington Hills Michigan — —
Not listed Nashua New Hampshire — —
Not listed Clementon New Jersey — —
Not listed Moorestown New Jersey — —
Not listed Albany New York — —
Not listed Olean New York — —
Not listed Cincinnati Ohio — —
Not listed Toledo Ohio — —
Not listed Philadelphia Pennsylvania — —
Not listed Austin Texas — —
Not listed Lake Jackson Texas — —
Not listed San Antonio Texas — —
Not listed Woodstock Vermont — —
Not listed Richmond Virginia — —
Not listed Seattle Washington — —
Not listed Brown Deer Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00036335, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 19, 2006 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00036335 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →